Skip to main content
VCbacked
Log inGet Started

Gate Bioscience

Brisbane, United States

Gate Bioscience is a biotechnology company that specializes in a small molecule modality to treat biology’s intractable diseases.

$65.0M raised
Nov 2025
Series B
BiotechnologyLife ScienceNanotechnology

Top Investors

Andreessen HorowitzARCH Venture PartnersEli LillyForbion Capital PartnersVersant Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Gate Bioscience

How much funding has Gate Bioscience raised?
Gate Bioscience has raised $65.0M in total funding. The most recent round was Series B. The last funding was announced in November 2025.
Who are Gate Bioscience's investors?
Gate Bioscience's investors include Andreessen Horowitz, ARCH Venture Partners, Eli Lilly, Forbion Capital Partners, Versant Ventures.
Where is Gate Bioscience headquartered?
Gate Bioscience is headquartered in Brisbane, United States.
What does Gate Bioscience do?
Gate Bioscience is a biotechnology company that specializes in a small molecule modality to treat biology’s intractable diseases.
What stage is Gate Bioscience at?
Gate Bioscience is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Gate Bioscience — Funding & Investors." VCBacked, November 13, 2025, https://www.vcbacked.co/company/gate-bioscience. Accessed June 4, 2026.
APA
VCBacked. (2025). Gate Bioscience — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/gate-bioscience
Wikipedia (cite web)
{{cite web |title=Gate Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/gate-bioscience |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong